documents: FDA-1992-S-0039-0013
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| id | agency_id | docket_id | title | document_type | subtype | posted_date | posted_year | posted_month | comment_start_date | comment_end_date | last_modified | fr_doc_num | open_for_comment | withdrawn | object_id |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| FDA-1992-S-0039-0013 | FDA | FDA-1992-S-0039 | CDER to the Division of Dockets Management Investigational New Drug Applications, New Drug Applications, Biologics Licensing Applications, Abbreviated New Drug Applications, Master Files, and Annual Reports, Memo 34 - Memorandum | Supporting & Related Material | Memorandum | 2007-09-13T04:00:00Z | 2007 | 9 | 2012-11-16T22:46:28Z | 0 | 0 | 090000648052892d |
Links from other tables
- 0 rows from regs_document_id in fr_regs_crossref